09.05.2017 Views

Encyclopedia of Health and Medicine

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

444 Index<br />

prescription drug abuse 4:349<br />

scheduled drug 4:170<br />

stimulants 4:350<br />

substance abuse 4:311, 313<br />

substance abuse treatment<br />

4:351, 352<br />

tolerance 4:354<br />

withdrawal syndrome 4:354<br />

Addison’s disease 2:67, 256;<br />

3:106–107, 106t<br />

adrenal insufficiency 3:109<br />

aldosterone 3:112<br />

cortisol 3:116<br />

Cushing’s syndrome 3:118<br />

hyperaldosteronism 3:137<br />

hypercalciuria 3:197<br />

hyponatremia 3:143<br />

adenocarcinoma 2:208, 366;<br />

3:17–18, 28, 40, 90, 91, 104 See<br />

also tumor, cancerous<br />

Adenocard. See adenosine<br />

adenoid hypertrophy 1:7–8<br />

adenoids 1:7–8, 58<br />

adenoma 3:107. See also tumor,<br />

noncancerous<br />

acromegaly 3:104<br />

adrenal gl<strong>and</strong>s 3:109<br />

Cushing’s syndrome 3:117<br />

hyperaldosteronism 3:137<br />

hypernatremia 3:138<br />

hyperparathyroidism 3:138<br />

MEN 3:151<br />

adenoma-to-carcinoma transition<br />

2: 366<br />

acromegaly 3:106<br />

adenoma 3:107<br />

adrenal gl<strong>and</strong>s 3:109<br />

colorectal cancer 3:31<br />

esophageal cancer 3:41<br />

FAP 3:43<br />

HNPCC 3:58<br />

intestinal polyp 3:64<br />

stomach cancer 3:91<br />

adenomyosis 3:241<br />

adenosine (Adenocard) 2:77, 84t<br />

adenosine triphosphate (ATP)<br />

3:128; 4:134<br />

adenovirus 2:221, 306<br />

ADH. See antidiuretic hormone<br />

ADHD. See attention deficit<br />

hyperactivity disorder<br />

adhesive capsulitis 1:298–299, 353<br />

adipose (fat) cells 3:126, 156, 160,<br />

249<br />

adipose tissue 1:128, 134–135,<br />

333–334<br />

adolescence 1:313; 4:215, 240,<br />

240t, 250, 292<br />

adoption 3:241–242, 281, 289<br />

adrenal cortex 3:99, 106, 111<br />

adrenal gl<strong>and</strong>s 3:107–109, 108t,<br />

109t<br />

ACTH 3:110<br />

Addison’s disease 3:106<br />

adrenal insufficiency 3:109<br />

<strong>and</strong>rogens 3:113<br />

cortisol 3:116<br />

CRH 3:116<br />

DHEA 3:119<br />

dopamine 3:124<br />

endocrine system 3:99<br />

epinephrine 3:125<br />

estrogens 3:126<br />

hyperaldosteronism 3:136<br />

hyperkalemia 3:138<br />

norepinephrine 3:152<br />

pheochromocytoma 3:154<br />

progesterone 3:156<br />

renin 3:158<br />

testosterone 3:160<br />

urinary system 3:171<br />

adrenal insufficiency 3:106,<br />

109–110, 110t, 131, 137, 138,<br />

143, 154<br />

adrenocorticotropic hormone<br />

(ACTH) 3:101, 106, 109, 110,<br />

112, 116, 117<br />

adult acne. See rosacea<br />

adult survivors <strong>of</strong> childhood cancer<br />

2:366–367<br />

adverse drug reaction 1:365, 384;<br />

4:148–149, 148t, 149, 163, 164,<br />

171, 318<br />

Advil. See ibupr<strong>of</strong>en<br />

AED. See automated external<br />

defibrillator<br />

aerobic bacteria 2:308, 346<br />

aerobic capacity 2:9, 73, 123;<br />

4:213, 213t<br />

aerobic exercise 4:214<br />

blood doping 4:324<br />

conditioning 4:217<br />

disability <strong>and</strong> exercise 4:220<br />

endurance 4:220<br />

fitness level 4:222<br />

physical activity<br />

recommendations 4:228<br />

strength 4:232<br />

training 4:233<br />

walking for fitness 4:235<br />

aerobic exercise 1:63; 2:27, 30, 97,<br />

194; 4:213–214, 214t<br />

aerobic capacity 4:213<br />

cross training 4:219<br />

physical activity<br />

recommendations 4:228<br />

resistance exercise 4:229<br />

strength 4:232<br />

training 4:233<br />

walking for fitness 4:235<br />

aerobic fitness 2:9, 9t<br />

aging <strong>and</strong> pulmonary changes<br />

2:183<br />

asthma 2:188<br />

breathing exercises 2:194<br />

cardiac capacity 2:27<br />

cardiac output 2:30<br />

COPD 2:201<br />

dyspnea 2:203<br />

heart rate 2:60<br />

AFP. See alpha fetoprotein<br />

African Americans 2:64, 165, 293,<br />

295, 296; 4:48, 255<br />

age 2:220, 222; 4:278<br />

age-related macular degeneration<br />

(ARMD) 1:69, 70–71, 73, 78;<br />

4:60, 79, 80, 107<br />

age spots. See lentigines<br />

aging, cancer <strong>and</strong> 2:365; 3:91, 251,<br />

253, 255, 256, 274, 275<br />

aging, cardiovascular changes that<br />

occur with 2:9–10, 27, 34, 49,<br />

98; 4:16<br />

aging, changes in pain perception<br />

that occur with 1:364–365<br />

aging, changes in physical ability<br />

<strong>and</strong> fitness needs that occur with<br />

4:214–215<br />

aging, changes in the blood <strong>and</strong><br />

lymph that occur with<br />

2:123–124<br />

aging, effects on drug metabolism<br />

<strong>and</strong> drug response 1:364–365;<br />

4:149–150<br />

aging, effects on immune response<br />

2:239, 275<br />

aging, endocrine changes that occur<br />

with 3:109, 110–111, 163, 164;<br />

4:76, 88<br />

aging, gastrointestinal changes that<br />

occur with 3:10, 32, 35, 46, 50,<br />

58, 64<br />

aging, integumentary changes that<br />

occur with 1:134–135, 210–211<br />

aging, musculoskeletal changes that<br />

occur with 1:298–299, 299–300,<br />

326–327, 341–342, 345–347, 350;<br />

4:72

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!